Article
Fabry disease in W162C mutation: a case report of two patients and a review of literature.
BMC neurology - 5 Apr 2024
Furia Alessandro, Ditaranto Raffaello, Biagini Elena, Parisi Vanda, Incensi Alex, Parisini Sara, Liguori Rocco, Donadio Vincenzo
Abstract excerpt
BACKGROUND: Fabry disease is a multisystemic disorder characterized by deposition of globotriaosylceramide (Gb3) and its deacylated form in multiple organs, sometimes localized in specific systems such as the nervous or cardiovascular system. As disease-modifying therapies are now available, early diagnosis is paramount to improving life quality and clinical outcomes. Despite the widespread use of non-invasive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
